Skip to content

A clinical study to evaluate the efficacy of Akika Pishti with Jatamansyadi Kwath in the management of Raktagata Vata (Essential Hypertension)

A randomized open-labelled comparative clinical study to evaluate the efficacy of Akika Pishti with Jatamansyadi Kwath in the management of Raktagata Vata (Essential Hypertension) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069945
Enrollment
60
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Institute For Ayurved Studies and Reasearch
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patient presented with cardinal features of Raktagata vata or Rakta dushti janya vikaras as described in Ayurvedic texts. 2. Randomly selected irrespective of their caste, religion and sex. 3. Patient with the age group of Age of 18-45 years. 4. Patients with prehypertension and stage 1 hypertension. 5. Willing and able to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patient below 18 years and above 45 years of age. 2. Patient with SBP =160 mmHg, DBP =100 mmHg. 3. Secondary Hypertension (Chronic kidney disease Hypothyroidism, Hyperthyroidism, Hyperaldosteronism, Uncontrolled diabetes mellitus). 4. The patient taking steroids, oral contraceptive pills and estrogen replacement therapy. 5. Patient having systemic/serious complication of Cardio-vascular/ Cerebro-vascular/ Renal system. 6. Patient having an illness such as Ischemic heart disease, Chronic renal failure etc. 7. Any type of malignancy 8. Alcoholics and any other drug abusers. 9. Pregnant and Lactating women. 10. Patient having a history of Hypersensitivity to the trial drug or any of its ingredients.

Design outcomes

Primary

MeasureTime frame
Improvement in symptoms of Hypertension such as Blood Pressure systolic and diastolic, redness of eyes, burning sensation, headache, fatigue without exertion, irritationTimepoint: at 28th day

Secondary

MeasureTime frame
Improvement in quality of life of patientsTimepoint: 56 days

Countries

India

Contacts

Public ContactDr Himanshu Bhusan Pradhan

Institute for Ayurved Studies and Research, SKAU, Kurukshetra

drlamba.neha@gmail.com9736333868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026